Despite a 102% revenue growth rate in 2026Q1, the company's operating margin remains deeply negative at -877.62% in recent periods, highlighting a fundamental inability to scale profitably.
| Sales/Revenue | 8.22M | 3.93M | 701.97K | 202.67K | 120.63K | 2.88M | 1.07M |
| Revenue Growth % | 687.25% | 459.81% | 246.36% | 68.01% | -95.81% | 169.9% | - |
| Cost of Goods Sold | 3.83M | 2.69M | 3.15M | 277.13K | 325.17K | 2.34M | 727.96K |
| COGS % of Revenue | - | 68.49% | 448.41% | 136.74% | 269.57% | 81.38% | 68.31% |
| Gross Profit | 4.4M | 1.24M | -2.45M | -74.46K | -204.54K | 535.49K | 337.7K |
| Gross Margin % | 53.48% | 31.51% | -348.41% | -36.74% | -169.57% | 18.62% | 31.69% |
| Gross Profit Growth % | - | 150.62% | -3184.79% | 63.6% | -138.2% | 58.57% | - |
| Operating Expenses | 32.09M | 35.73M | 39.61M | 12.52M | 11.63M | 17.31M | 5.47M |
| OpEx % of Revenue | - | 909.13% | 5642.99% | 6179.93% | 9640.28% | 601.7% | 513.56% |
| Selling, General & Admin | 32.41M | 35.73M | 39.61M | 12.52M | 11.63M | 17.31M | 5.16M |
| SG&A % of Revenue | - | 909.13% | 5642.99% | 6179.93% | 9640.28% | 601.7% | 484.62% |
| Research & Development | 15.48K | 0 | 0 | 0 | 0 | 0 | 308.37K |
| R&D % of Revenue | - | - | - | - | - | - | 28.94% |
| Other Operating Expenses | -337.22K | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -27.69M | -34.49M | -42.06M | -12.6M | -11.83M | -16.77M | -5.14M |
| Operating Margin % | -336.71% | -877.62% | -5991.4% | -6216.67% | -9809.85% | -583.09% | -481.87% |
| Operating Income Growth % | - | 18% | -233.81% | -6.47% | 29.44% | -226.6% | - |
| EBITDA | -26.94M | -33.83M | -41.63M | -12.39M | -11.81M | -16.58M | -4.97M |
| EBITDA Margin % | -327.56% | -860.97% | -5930.31% | -6111.01% | -9792.78% | -576.55% | -466.73% |
| EBITDA Growth % | 16.11% | 18.73% | -236.12% | -4.85% | 28.77% | -233.42% | - |
| D&A (Non-Cash Add-back) | 752.81K | 654.38K | 428.83K | 214.14K | 20.59K | 187.92K | 161.37K |
| EBIT | -60.95M | -67.59M | -48.24M | -14.65M | -14.28M | -26.36M | -6.17M |
| Net Interest Income | -430.23K | -500.41K | -118.33K | -114.09K | -1.28M | -1.73M | -113.77K |
| Interest Income | 107.71K | 92.09K | 57.6K | 57.34K | 1.7K | 7.32K | 3.04K |
| Interest Expense | 537.94K | 592.5K | 175.93K | 171.43K | 1.29M | 1.74M | 116.8K |
| Other Income/Expense | -36.96M | -33.7M | -6.35M | -2.22M | -3.73M | -11.33M | -1.15M |
| Pretax Income | -64.66M | -68.19M | -48.41M | -14.82M | -15.57M | -28.1M | -6.29M |
| Pretax Margin % | -786.15% | -1735.16% | -6896.6% | -7313.13% | -12905.24% | -976.97% | -590.17% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -64.69M | -68.19M | -49.41M | -15.08M | -15.22M | -28.1M | -6.29M |
| Net Margin % | -786.51% | -1735.16% | -7038.74% | -7442.17% | -12619.92% | -976.97% | -590.17% |
| Net Income Growth % | -65.6% | -38% | -227.58% | 0.92% | 45.83% | -346.8% | - |
| Net Income (Continuing) | -64.66M | -68.19M | -48.41M | -14.82M | -15.57M | -28.1M | -6.29M |
| Discontinued Operations | 0 | 0 | -997.8K | -261.53K | 344.17K | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -15.07 | -15.88 | -31.85 | -17.15 | -24.15 | -59.15 | -30.10 |
| EPS Growth % | 38.87% | 50.14% | -85.71% | 28.99% | 59.17% | -96.51% | - |
| EPS (Basic) | - | -15.88 | -31.85 | -17.15 | -24.15 | -59.15 | -30.10 |
| Diluted Shares Outstanding | 4.29M | 4.29M | 1.56M | 882.22K | 631.62K | 474.39K | 209.31K |
| Basic Shares Outstanding | 4.29M | 4.29M | 1.56M | 882.22K | 631.62K | 474.39K | 208.94K |
| Dividend Payout Ratio | - | - | - | - | - | - | - |
Regulatory and Liquidity Constraints
As reported in recent financial statements, BNKK achieved a 102% quarterly revenue growth rate in 2026Q1, yet this rapid expansion appears heavily reliant on initial distributor stocking rather than established consumer pull-through, warranting caution regarding the long-term durability of these top-line gains in a competitive beverage landscape.
The dramatic revenue acceleration suggests a successful initial market entry, but the lack of recurring revenue models makes this growth highly susceptible to volatility. Investors should monitor whether subsequent quarters demonstrate consistent repeat purchases or if the current trajectory is merely a function of aggressive, non-repeatable retail channel filling.
Based on the company's reported figures, gross margins have fluctuated wildly from negative territory to a peak of 78% in 2026Q1, suggesting that the firm lacks the stable pricing power or cost control typical of established players in the non-alcoholic beverage sector.
The extreme variance in gross margins implies significant instability in production costs or potential accounting adjustments related to inventory valuation. Such inconsistency makes it difficult to forecast long-term profitability, as the company appears unable to maintain a consistent premium margin profile despite its specialized product positioning.
According to historical income statements, BNKK's operating expenses consistently dwarf gross profits, with the company recording an operating margin of -877.62% in recent periods, indicating that current overhead levels are entirely disproportionate to the scale of revenue generated by the business.
The inability to scale operating income alongside revenue growth suggests that the company is currently prioritizing market share acquisition through unsustainable spending. Without a significant reduction in SG&A relative to revenue, the firm may continue to face severe pressure on its operating leverage, limiting its path to self-sufficiency.
As evidenced by the provided data, net income figures are frequently impacted by significant stock-based compensation charges, which reached $9.4M in 2025Q4, obscuring the underlying operational performance and complicating the assessment of true economic profitability for the firm.
The reliance on equity-based incentives to manage cash flow suggests a potential misalignment between reported net income and actual cash generation. Analysts should adjust for these non-cash items to better understand the core operational burn rate, as the current earnings profile appears heavily influenced by accounting maneuvers rather than fundamental business success.
Based on an analysis of the company's core product claims, the primary risk is not merely operational, but existential, as any regulatory challenge to the metabolic alcohol-reduction claims could invalidate the entire revenue model, a risk that appears under-appreciated in the current speculative valuation.
Short-sellers would likely focus on the high probability of regulatory scrutiny regarding the company's health claims, which could lead to product recalls or marketing injunctions. Given the lack of clinical validation, the company's reliance on a single, unproven product feature creates a binary outcome that could render the current growth trajectory irrelevant.
Quick answers to the most common questions about buying BNKK stock.
For fiscal year 2025, Bonk, Inc. (BNKK) reported total revenue of $3.9M. This represents a 268.8% increase compared to $1.1M in 2020.
Bonk, Inc. (BNKK) reported a net loss of $68.2M for the fiscal year ending 2025.
Bonk, Inc. (BNKK) reported an operating income of $-34.5M, resulting in an operating profit margin of -877.6%. This margin reflects the operational efficiency of the business before interest and taxes.
Bonk, Inc. (BNKK) generated $1.2M in gross profit for the year, representing a gross profit margin of 31.5%. This demonstrates the company's core pricing power and production efficiency.